These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 15888188)

  • 41. Integrating colocated behavioral health care into a dermatology clinic: A prospective randomized controlled treatment pilot study in patients with alopecia areata.
    Gorbatenko-Roth K; Hodges JS; Lifson D; Golm M; Kranz D; Windenburg D; Hordinsky M
    J Am Acad Dermatol; 2021 May; 84(5):1487-1489. PubMed ID: 32707246
    [No Abstract]   [Full Text] [Related]  

  • 42. Alopecia and its medical management.
    Chan EF
    Facial Plast Surg Clin North Am; 2003 May; 11(2):267-76. PubMed ID: 15062279
    [No Abstract]   [Full Text] [Related]  

  • 43. Lack of efficacy of topical latanoprost and bimatoprost ophthalmic solutions in promoting eyelash growth in patients with alopecia areata.
    Roseborough I; Lee H; Chwalek J; Stamper RL; Price VH
    J Am Acad Dermatol; 2009 Apr; 60(4):705-6. PubMed ID: 19293023
    [No Abstract]   [Full Text] [Related]  

  • 44. Poor long term outcome of severe alopecia areata in children treated with high dose pulse corticosteroid therapy.
    Hubiche T; Léauté-Labrèze C; Taïeb A; Boralevi F
    Br J Dermatol; 2008 May; 158(5):1136-7. PubMed ID: 18279461
    [No Abstract]   [Full Text] [Related]  

  • 45. [Development of the evidence-based guidelines for psoriasis--a project of the German Dermatological Society (DDG)].
    Follmann M; Sterry W; Rzany B; ;
    J Dtsch Dermatol Ges; 2005 Sep; 3(9):678-89. PubMed ID: 16173975
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Evidence-based medicine, systematic reviews, and guidelines in interventional pain management, part I: introduction and general considerations.
    Manchikanti L
    Pain Physician; 2008; 11(2):161-86. PubMed ID: 18354710
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Topical immunotherapy with diphenylcyclopropenone in the treatment of chronic extensive alopecia areata.
    Sotiriadis D; Patsatsi A; Lazaridou E; Kastanis A; Vakirlis E; Chrysomallis F
    Clin Exp Dermatol; 2007 Jan; 32(1):48-51. PubMed ID: 17004987
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Discoid lupus erythematosus exacerbated by contact dermatitis caused by use of squaric acid dibutylester for topical immunotherapy in a patient with alopecia areata.
    Shimaoka Y; Hatamochi A; Hamasaki Y; Suzuki H; Ikeda H; Yamazaki S
    J Dermatol; 2008 Mar; 35(3):151-3. PubMed ID: 18346258
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Value of transverse section scalp biopsy in alopecia areata - a clinicopathological correlation.
    Jameel K; Ejaz A; Sohail M; Rahman SB
    J Coll Physicians Surg Pak; 2008 Jun; 18(6):338-41. PubMed ID: 18760043
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Therapy versus placebo for alopecia areata.
    Hutchinson E
    J Am Acad Dermatol; 1987 Sep; 17(3):516-7. PubMed ID: 3308984
    [No Abstract]   [Full Text] [Related]  

  • 51. A case of patchy alopecia areata sparing lesional greying hairs.
    Tan C; Zhu WY; Min ZS
    Int J Dermatol; 2008 Aug; 47(8):864-5. PubMed ID: 18717874
    [No Abstract]   [Full Text] [Related]  

  • 52. The non-synonymous C1858T substitution in the PTPN22 gene is associated with susceptibility to the severe forms of alopecia areata.
    Kemp EH; McDonagh AJ; Wengraf DA; Messenger AG; Gawkrodger DJ; Cork MJ; Tazi-Ahnini R
    Hum Immunol; 2006 Jul; 67(7):535-9. PubMed ID: 16829308
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Alopecia areata in Down syndrome: a clinical evaluation.
    Schepis C; Barone C; Lazzaro Danzuso GC; Romano C
    J Eur Acad Dermatol Venereol; 2005 Nov; 19(6):769-70. PubMed ID: 16268894
    [No Abstract]   [Full Text] [Related]  

  • 54. Dermal mucin in alopecia areata--tell tale sign or incidental finding?
    Goldberg LJ; Sekhri V; Bhawan J
    J Cutan Pathol; 2008 Aug; 35(8):757-60. PubMed ID: 18201227
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Alopecia areata with comorbid depression: early resolution with combined paroxetine-triamcinolone treatment.
    Ricciardi A; Ruberto A; García-Hernández MJ; Kotzalidis GD; Trevisi M; Persechino S; Tatarelli R; Ruiz-Doblado S
    J Eur Acad Dermatol Venereol; 2006 Sep; 20(8):1000-1. PubMed ID: 16922952
    [No Abstract]   [Full Text] [Related]  

  • 56. Two novel molecular mechanisms to account for the therapeutic efficacy of contact dermatitis against alopecia areata.
    Namazi MR
    Int Immunopharmacol; 2006 May; 6(5):862. PubMed ID: 16546718
    [No Abstract]   [Full Text] [Related]  

  • 57. The ethical issue of cherry picking patients.
    Morrell TJ; Konda S; Grant-Kels JM
    J Am Acad Dermatol; 2019 May; 80(5):1463-1465. PubMed ID: 29906545
    [No Abstract]   [Full Text] [Related]  

  • 58. A critical appraisal of evidence-based guidelines for the treatment of psoriasis vulgaris: 'AGREE-ing' on a common base for European evidence-based psoriasis treatment guidelines.
    Nast A; Spuls PH; Ormerod AD; Reytan N; Saiag PH; Smith CH; Rzany B
    J Eur Acad Dermatol Venereol; 2009 Jul; 23(7):782-7. PubMed ID: 19298485
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Alopecia areata treatment with a phototoxic dose of UVA and topical 8-methoxypsoralen.
    Mohamed Z; Bhouri A; Jallouli A; Fazaa B; Kamoun MR; Mokhtar I
    J Eur Acad Dermatol Venereol; 2005 Sep; 19(5):552-5. PubMed ID: 16164707
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Evidence-based dermatology: some problems with research.
    Sladden MJ
    Arch Dermatol; 2006 Dec; 142(12):1650. PubMed ID: 17178999
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.